EYPT News and Press, EyePoint Pharmaceuticals Inc. From 01/24/23

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Eyepoint To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - January 24, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is...

EyePoint Pharmaceuticals ( NASDAQ: EYPT ) said it signed a lease agreement to design and construct a 40K square-foot manufacturing facility in Northbridge, Massachusetts for its programs, including EYP-1901 and Yutiq. The facility, which will be Good Manufacturing Practice (GMP) ...

– State-of-the-art cGMP manufacturing facility to be built in Northbridge, Massachusetts – – Awarded $1.9 million of state and local grants with rent commencing in second half of 2024 – WATERTOWN, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceutic...

– Topline data for Phase 2 DAVIO 2 clinical trial in wet AMD expected in 4Q 2023 – – Enrollment remains on-track in Phase 2 DAVIO 2 clinical trial for wet AMD and Phase 2 PAVIA clinical trial for NPDR – – Full-year 2022 net product revenue estimated to...

EyePoint Pharmaceuticals ( NASDAQ: EYPT ) promotes company's COO since November 2021, Jay S. Duker, M.D.,  to the additional role of President. In addition to continuing to oversee his duties as COO, in his expanded role, Dr. Duker will also oversee regula...

WATERTOWN, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced that Jay S. Duker, M.D., who has served...

NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against against GrafTech International Ltd. (NYSE: EAF), BRP Group, Inc. (NASDAQ: BRP), Cantaloupe, Inc. (NASDAQ: CTLP, OTCMKTS: CTLP...

Penny Stocks To Buy According To 5 Wall Street Analysts Today we look at a handful of penny stocks to buy, according to Wall Street analysts. It’s an interesting phenomenon when traders use ratings as part of their research methodologies. Sure, the so-called “smart mon...

Start Time: 08:30 End Time: 09:13 EyePoint Pharmaceuticals, Inc. (EYPT) Q3 2022 Earnings Conference Call November 02, 2022, 08:30 AM ET Company Participants Nancy Lurker - President and CEO George Elston - CFO Jay Duker - COO Scott Jones - Chief Comme...

EyePoint Pharmaceuticals press release ( NASDAQ: EYPT ): Q3 GAAP EPS of -$0.49 beats by $0.16 . Revenue of $10.01M (+10.5% Y/Y) misses by $0.91M . Cash and investments at September 30, 2022 totaled $157.3 million compared to $171.2 million at June 30, 2022. ...